Novo Nordisk Says Summary Judgment Award In Semaglutide Spat Needs Amending
TAMPA, Fla. — Novo Nordisk Inc. on June 9 urged a Florida federal court to amend its order granting summary judgment in favor of a pharmaceutical company accused of selling unapproved...To view the full article, register now.
Already a subscriber? Click here to view full article